Stem Cell Research Enhancement Act of 2005

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.- H.R.2679, Public Expression of Religion Act -- CWALAC supports this bill.- S193, Broadcast Decency Enforcement Act -- CWALAC supports this bill- and more that will not fit.

Client expense: Not reported · Firm income: Not reported

S.396, Child Custody protection Act -- CWALAC supports this bill. S.51, Unborn Child Pain Awareness Act of 2005 -- CWALAC supports this bill. S. 8, Child Custody Protection Act -- CWALAC supports this bill. H.R. 1079, Holly's Law -- CWALAC supports this bill. H.R. 810, Stem Cell Research Enhancement Act -- CWALAC opposes this bill. H.R.748, Child Interstate Abortion Notification Act -- CWALAC supports this bill. H.R.596, Cord Blood Stem Cell Act -- CWALAC supports this bill. H.R.305, Adoption Tax Relief Guarantee Act of 2005 -- CWALAC supports this bill. S.3504, Fetal Farming Prohibition Act of 2006 -- CWALAC supports this bill. S.681, Cord Blood Stem Cell Act of 2006 -- CWALAC supports this bill. S.658, Human Cloning Prohibition Act -- CWALAC supports this bill. S.471, Stem Cell Research Enhancement Act -- CWALAC opposes this bill.

Client expense: $73,530 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 334, Pharmaceutical Market Access and Drug Safety Act of 2005. S 471, Stem Cell Research Enhancement Act of 2005. Biologics, generics, importation issues. FDA issues. Drug safety issues. Clinical trial issues. Conflict of interest, follow on biologics, steroid abuse, stem cells. PDUFA. HR 2090, Food and Drug Administration Improvement Act of 2005. S 2766, National Defense Authorization Act for Fiscal Year 2007; Drug pricing issues. HR 328, Pharmaceutical Market Access Act of 2005. HR 6143, Ryan White HIV/AIDS Treatment Modernization Act of 2006. S 3807, Bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. S 4016 & HR 6257, Bill to amend the Public Health Service Act to provide for the licensing of comparable biological products, and for other purposes HR 2565, Office of National Drug Control Reauthorization Act. HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005. HR 810, Stem Cell Research Enhancement Act of 2005. S 109, Pharmaceutical Market Access Act of 2005.

Client expense: Not reported · Firm income: $120,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Federal funding and procedures for stem cell research, incl. H.R. 810/S. 471, H.R. 5526/S. 2754 & H.R. 5719/S. 3504 Medicaid funding and reform (incl. consent decrees, H.R. 1229 & S. 489) proposals

Client expense: $109,012 · Firm income: Not reported

Government targets: Education, Dept of, Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

NEA/NEH/CPB funding District of Columbia’s voucher program, incl. H.R. 5576/S. 3660 (FY07 DC appropriations) School vouchers, incl. H.R. 5822 & S. 3682, as well as applicable provisions in H.R. 6111, H.R. 6408 & H.R. 3010/5647/S. 3708 Title X and abstinence-only education funding in the Labor-HHS-Education appropriations bill (H.R. 3010/5647 & S. 3708) Federal Refusal Clause in the Labor-HHS-Education appropriations bill (H.R. 3010/5647 & S. 3708), as well as related conscience protections 9th Circuit split proposals, incl. S. 1845 Line-item veto legislation, incl. H.R. 4890 & S. 2381, as well as applicable provisions in S. 3521 Sunset commission legislation, incl. H.R. 3277, H.R. 3282 & H.R. 5766, as well as applicable provisions in S. 3521 Federal funding and procedures for stem cell research, incl. H.R. 810/S. 471, H.R. 5526/S. 2754 & H.R. 5719/S. 3504 Immigration reform proposals, incl. H.R. 2330, H.R. 4830, H.R. 6061, S. 1033, S. 3564, S. 2611 & S. 2612, as well as applicable provisions in H.R. 5441 & H.R. 5631 Continuing resolutions for Fiscal Year 2007 appropriations, incl. H.R. 5631, H.J.Res. 100, H.J.Res. 102 Section 203/Voting Rights Act amendment to H.R. 5672 Federal minimum wage, incl. applicable provisions in H.R. 366, H.R. 3010/5647, H.R. 5672, H.R. 5970, S. 2766 & S. 3708 Medicaid funding and reform (incl. consent decrees, H.R. 1229 & S. 489) proposals

Client expense: $109,012 · Firm income: Not reported

Government targets: Education, Dept of, Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

NEA/NEH/CPB funding District of Columbia’s voucher program, incl. H.R. 5576/S. 3660 (FY07 DC appropriations) School vouchers, incl. H.R. 5822 & S. 3682, as well as applicable provisions in H.R. 6111, H.R. 6408 & H.R. 3010/5647/S. 3708 Title X and abstinence-only education funding in the Labor-HHS-Education appropriations bill (H.R. 3010/5647 & S. 3708) Federal Refusal Clause in the Labor-HHS-Education appropriations bill (H.R. 3010/5647 & S. 3708), as well as related conscience protections 9th Circuit split proposals, incl. S. 1845 Line-item veto legislation, incl. H.R. 4890 & S. 2381, as well as applicable provisions in S. 3521 Sunset commission legislation, incl. H.R. 3277, H.R. 3282 & H.R. 5766, as well as applicable provisions in S. 3521 Federal funding and procedures for stem cell research, incl. H.R. 810/S. 471, H.R. 5526/S. 2754 & H.R. 5719/S. 3504 Immigration reform proposals, incl. H.R. 2330, H.R. 4830, H.R. 6061, S. 1033, S. 3564, S. 2611 & S. 2612, as well as applicable provisions in H.R. 5441 & H.R. 5631 Continuing resolutions for Fiscal Year 2007 appropriations, incl. H.R. 5631, H.J.Res. 100, H.J.Res. 102 Section 203/Voting Rights Act amendment to H.R. 5672 Federal minimum wage, incl. applicable provisions in H.R. 366, H.R. 3010/5647, H.R. 5672, H.R. 5970, S. 2766 & S. 3708 Medicaid funding and reform (incl. consent decrees, H.R. 1229 & S. 489) proposals

Client expense: $109,012 · Firm income: Not reported

Government targets: Education, Dept of, Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

Federal funding and procedures for stem cell research, incl. H.R. 810/S. 471, H.R. 5526/S. 2754 & H.R. 5719/S. 3504 Medicaid funding and reform (incl. consent decrees, H.R. 1229 & S. 489) proposals

Client expense: $109,012 · Firm income: Not reported

Government targets: Education, Dept of, Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 810, S. 471, Stem Cell Research Enhancement Act S. 1057, Indian Health Care Improvement Act Amendments of 2005 Authorizing states to cover children aging out of foster care to retain medical coverage until 21

Client expense: $560,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Commission on Civil Rights, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office

H.R.1357/S.658 Human Cloning Prohibition Act of 2005; H.R. 596/S.681 Cord Blood Stem Cell Act of 2005; H.R. 2574 Respect for Life Embryonic Stem Cell Act of 2005; H.R. 810/S.471 Stem Cell Research Enhancement Act of 2005; S.2754/H.R.5526 Alternative Pluripotent Stem Cell Therapies Enhancement Act; S.3504/H.R.5719 Fetus Farming Prohibition Act.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office

S. 2754 - Alternative Pluripotent Stem Cell Therapies Enhancement Act S. 471 - Stem Cell Research Enhancement Act of 2005 H.R. 810 - Stem Cell Research Enhancement Act of 2005

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 525, Small Business Health Fairness Act; HR 810 & S. 471, Stem Cell Research Enhancement Act of 2005; HR 2355 & S. 1015, Health Care Choice Act of 2005; S. 366, Healthy Mothers and Healthy Babies Access to Care Act of 2005; HR 4157, Health Information Technology Promotion Act of 2005; S. 1574 & HR 2356, Preserving Patient Access to Physicians Act of 2005; HR 5118, Medicare Rural Health Provider Payment Extension Act of 2006. S. 1418, Health Information Technology Act; S. 4, Healthy America Act; S. 544, Patient Safety and Quality Act; HR 5 & HR 3378, Medical Liability Reform Act;

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR5647 – Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 HR810 - Stem Cell Research Enhancement Act of 2005 S471 – Stem Cell Research Enhancement Act of 2005 S2754 - Alternative Pluripotent Stem Cell Therapies Enhancement Act HR1357 - Human Cloning Prohibition Act of 2005 HR5574 - Children's Hospital GME Support Reauthorization Act of 2006 HR5573 - Health Centers Renewal Act of 2006 S22 - Medical Care Access Protection Act of 2006 HR4997 - Physicians for Underserved Areas Act S2425 - To apply amendments to the Immigration and Nationality Act related to providing medical services in underserved areas, and for other purposes S2564 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006 S3504 - Fetus Farming Prohibition Act of 2006 S843 - Combating Autism Act of 2006 HR6164 - National Institutes of Health Reform Act of 2006 HR4239 - Animal Enterprise Terrorism Act HR5533 - Biodefense and Pandemic Vaccine and Drug Development Act of 2006

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Office of the Vice President of the United States, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)

S.3504, Fetus Farming Prohibition Act of 2006 H.R.5647/S.3708, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007 (funding for biomedical research) H.R.6164, National Institutes of Health Reform Act of 2006 Discussions regarding Small Business Administration research grants Discussions regarding NIH funding H.R.810/S.471, Stem Cell Research Enhancement Act of 2005 S.2754, Alternative Pluriopotent Stem Cell Therapies Enhancement Act

Client expense: $520,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), SENATE, Small Business Administration (SBA)

H.R. 5356 – A bill to authorize the National Science Foundation and the Department of Energy Office of Science to provide grants to early career researchers to establish innovative research programs and integrate education and research, and for other purposes. (All) H.R. 5358 – A bill to authorize programs relating to science, mathematics, engineering, and technology education at the National Science Foundation and the Department of Energy Office of Science, and for other purposes. (All) S. 39 – A bill to establish a coordinated national ocean exploration program within the National Oceanic and Atmospheric Administration. (All) S. 361 – A bill to develop and maintain an integrated system of ocean and coastal observations for the Nation's coasts, oceans and Great Lakes, improve warnings of tsunamis and other natural hazards, enhance homeland security, support maritime operations, and for other purposes. (All) S. 471 – A bill to amend the Public Health Service Act to provide for human embryonic stem cell research. (All) S. 658 – A bill to amend the Public Health Service Act to prohibit human cloning. (All) S. 876 – A bill to prohibit human cloning and protect stem cell research. (All) S. 1520 – A bill to prohibit human cloning. (All) S. 2197 – A bill to ensure the United States successfully competes in the 21st century global economy. (Provisions concerning the Office of Science, Department of Energy) S. 2198 – A bill to ensure the United States successfully competes in the 21st century global economy. (All) S. 2793 – A bill to enhance research and education in the areas of pharmaceutical and biotechnology science and engineering, including therapy development and manufacturing, analytical technologies, modeling, and informatics. (All) S. 3880 - A bill to provide the Department of Justice the necessary authority to apprehend, prosecute, and convict individuals committing animal enterprise terror (All). S. 3936 - A bill to invest in innovation and education to improve the competitiveness of the United States in the global economy (All). H.R. 810 - To amend the Public Health Service Act to provide for human embryonic stem cell research. (All) H.R. 3835 - A bill to establish a coordinated national ocean exploration program within the National Oceanic and Atmospheric Administration. (All)

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Stem Cell Research Enhancement Act of 2005 (H.R. 810, S. 471)

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 2772 Reauthorization of NIH Legislation; S. 1171/H.R. 1245 Gynecologic Cancer Education and Awareness Act; S. 306/H.R. 1227 Genetic Information Nondiscrimination Act of 2005; S. 471 Stem Cell Research Enhancement Act; H.R. 1522 Troops to Teachers Improvement Act of 2006

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

* Issue: Maintaining key functions of the Armed Forces Institute of Pathology within the Department of Defense, Uniformed Services University of the Health Sciences. H.R. 810/S. 471, "Stem Cell Research Enhancement Act of 2005" Issue: Support the expansion of federal funding for human embryonic stem cell research. 21

Client expense: $240,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)

SCI HR 1357 Human Cloning Prohibition Act of 2005 To amend title 18, United States Code, to prohibit human cloning. SCI HR 1822 Human Cloning Ban and Stem Cell Research Protection Act of 2005 Prohibits human cloning and protects stem cell research SCI HR 2574 Respect for Life Embryonic Stem Cell Act of 2005 Supports stem cell research on animals so embryos are not harmed SCI HR 3144 Respect for Life Pluripotent Stem Cell Act of 2005 Supports research on human pluripotent stem cells without harming embryos SCI HR 3932 Human Cloning Ban Act of 2005 "To prohibit human cloning." SCI S 471 Stem Cell Research Enhancement Act of 2005 Provision for embryonic stem cell research SCi S 658 Human Cloning Prohibition Act of 2005 Prohibit human cloning SCI S 876 Human Cloning Ban and Stem Cell Research Protection Act of 2005 A bill to prohibit human cloning and protect stem cell research SCI S 1520 Human Cloning Ban Act of 2005 A bill to prohibit human cloning. SCI HR 810 Stem Cell Research Enhancement Act of 2005 To amend the Public Health Service Act to provide for human embryonic stem cell research

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support: HR 1357/S. 658 (ban on human cloning); (continued) (continued) Support: HR 356, HR 6099, S. 51 (Unborn Child Pain Awareness Act); S. 2754/HR 5526 (alternative sources of pluripotent stem cells); S. 3504/HR 5719 (Fetus Farming Prohibition Act); retention of Weldon provision of HR 5672 (barring patents on humans). Oppose: HR 1822, S. 876, S. 1520 (legislation to adopt clone-and-kill policy for human embryos. In opposition to HR 810/S. 471 (to mandate federal funding of stem cell research that requires killing human embryos). Opposition to HR 1650 (to grant tax credits for bonds on embryo-killing research). Support for executive policies consistent with the above.

Client expense: $184,455 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Vice President of the U.S.

Support: HR 1357 and S. 658 (bans on human cloning); (continued) (continued) HR 356, HR 6099, S. 51 (Unborn Child Pain Awareness); S. 2754 /HR 5526 (alternative sources of pluripotent stem cells); S. 3504/HR 5719 (Fetus Farming Prohibition). Oppose: HR 1822, HR 3932, S. 876, S. 1520, bills to authorize human clone-and-kill policy. Oppose: HR 810/S.471 to mandate federal funding of research that requires the killing of human embryos. Support for executive policies consistent with the above. Support: HR 216/S.755 (grants for ultrasound equipment); HR 1079/S. 511 (restrictions on RU-486 abortion pill); S. 2206 (Title X reform). Support retention of Weldon provision of HR 5672 (to bar patents on human organisms).

Client expense: $184,455 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Vice President of the U.S.

* HR5427 Making appropriations for energy and water development for the fiscal year ending September 30, 2007, and for other purposes – All provisions relating to research, and the DOE Office of Science HR5672 Making appropriations for Science, the Departments of State, Justice, and Commerce, and related agencies for the fiscal year ending September 30, 2007, and for other purposes – All provisions relating to National Science Foundation, NASA, and other relevant research issues HR5631 Making appropriations for the Department of Defense for the fiscal year ending September 30, 2007, and for other purposes – All provisions relating to applied and basic research HR4596 To authorize appropriations for basic research and research infrastructure in science and engineering, and for support of graduate fellowships, and for other purposes – All HR5356 To authorize the National Science Foundation and the Department of Energy Office of Science to provide grants to early career researchers to establish innovative research programs and integrate education and research, and for other purposes – All HR5358 To authorize programs relating to science, mathematics, engineering, and technology education at the National Science Foundation and the Department of Energy Office of Science, and for other purposes – All HR6164 The National Institutes of Health Reform Act of 2006- All S2109 National Innovation Act of 2005 – All S2197 Protecting America’s Competitive Edge Through Energy Act of 2006 – All S2357 Right Time to Reinvest in America's Competitiveness and Knowledge Act – All provisions relating to research and development, and education S2802 American Innovation and Competitiveness Act of 2006 – All S3936 National Competitiveness Investment Act- All The President’s American Competitiveness Initiative HR810, S471 To amend the Public Health Service Act to provide for human embryonic stem cell research – All HR1357, S658 Human Cloning Prohibition Act of 2005 – All HR1822, S876 To prohibit human cloning and protect stem cell research – All HR2520, S1317 Stem Cell Therapeutic and Research Act of 2005 – All HR5647, S3708 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2007, and for other purposes – All provisions relating to National Institutes of Health, CDC and health professions training accounts Issues relating to the expansion of the Administration’s stem cell policy HR5122, S2766 National Defense Authorization Act for Fiscal Year 2007 – All provisions relating to science, research, and foreign language funding at the Department of Defense HR4239, S1926 A bill to provide the Department of Justice the necessary authority to apprehend, prosecute, and convict individuals committing animal enterprise terror – All provisions protecting research from terrorist intimidation or disruption 6

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 810/S 471 Stem Cell Research Enhancement Act of 2005 (entire bills). HR 2520/S 1317, Stem Cell Therapeutic and Research Act of 2005 (entire bills). HR 4157, the Health Information Technology Promotion Act of 2005 (entire bill). HR 6164, NIH Reform Act (entire bill).

Client expense: $400,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 810, S 471; The Stem Cell Research Enhancement Act HR 6143 The Ryan White HIV/AIDS Treatment Modernization Act of 2006

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.810/S.471, Stem Cell Research Enhancement Act of 2005 S.2754, Alternative Pluripotent Stem Cell Therapies Enhancement Act S.3504, Fetus Farming Prohibition Act of 2006 H.R.5647/S.3708, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007

Client expense: $560,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), SENATE, State, Dept of (DOS)

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

Client expense: $600,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Aeronautics & Space Administration (NASA), SENATE, State, Dept of (DOS), White House Office

S. 16: A bill to reduce to the cost of quality health care coverage and improve the availability of health care coverage for all Americans. Lobbied to protect the interests of the Biotech drug industry. S. 109, H.R. 328: A bill entitled the "Pharmaceutical Market Access Act of 2005". Lobbied for an exemption for biologics.S.184,H.R. 753: A bill to amend the Federal Food, Drug, and Cosmetic Act to protect the public health from the unsafe importation of prescription drugs and from counterfeit prescription drugs, and for other purposes. Lobbied for an exemption for biologics. S. 334, H.R. 700: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. Lobbied for an exemption for biologics. H.R. 563: To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate and disclose lowest possible prices for prescription drug prices for Medicare beneficiaries, and with respect to the Federal Food, Drug, and Cosmetic Act, to provide waivers that permit such beneficiaries to import prescription drugs from Canada. Lobbied for an exemption for biologics. H.R. 578: To amend the Internal Revenue Code of 1986 with respect to the purchase of prescription drugs by individuals who have attained retirement age, and to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs and the sale of such drugs through Internet sites. Lobbied for an exemption for biologics. H.R.1626: To amend part D of the title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negptiate for lower prices for Medicare prescription drugs and to eliminate the gap in coverage of Medicare prescrition durg benefits, to the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes. Lobbied for an exemption for biologics. H.R. 2599: To improve the quality, availability, diversity, personal privacy, and innovation of health care in the United States. Lobbied for an exemption for biologics.. H.R.16: To authorize the use of Federal funds for research on human embryonic stem cells irrrespective of the date on which such stem cells were derived, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 596, S. 681: To amend the Public Health Service Act to establish a National Cord Blood Stem Cell Bank Network to prepare, store, and distribute human umbilical cord blood stem cells for the treatment of patients and to support peer-reviewed research using such cells. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 810, S. 471: To amend the Public Health Service Act to provide for human embryonic stem cell research. H.R.1650: To amend the Internal Revenue Code of 1986 to allow tax credits to holders of stem cell research bonds. Lobbied to prevent the unreasonable restriciton of legitimate medical research or clinical trials. H.R. 1822, S. 876: To prohibit human cloning and protect stem cells research. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 2541: To amend the Public Health Service Act to provide for the expansion, intensification, and coordination of the activities of the National Institutes of Health regarding qualifying adult stem cell research, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R.2520, S.1317: To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. H.R. 2574: To amend the Public Health Service Act to provide for a program at the National Institutes of Health to conduct and support research on animals to develop techniques for the derivation of stem cells from embryos that do not harm the embryos, and for other purposes. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. S.1392: A bill to reauthorize the Federal Trade Commission. (Dorgan/Snowe Drug Importation Amendment). Lobbied for an exemption for biologics. H.R.3144: To amend the Public Health Service Act to provide for a program at the National Institutes of Health to conduct and support research in the derivation and use of human pluripotent stem cells by means that do not harm human embryos, and for other purposes. Lobbied for the interests of the vaccine industry. H.R.3423,S.1420: To amend the Federal Food, Drug, and Cosmetic Act with respect to medical device user fees. Lobbied for the interests of the medical device industry. S.226: A bill to amend the Public Health Service Act to improve immunization rates by increasing the supply of vaccines. Lobbied for the interst of the vaccine industry. S.521,H.R.1290: A bill to amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish, promote, and support a comprehensive prevention, research, and medical management referral program for hepatitis C virus infection. Supported bill. S.969,H.R.3369: A bill to amend the Public Health Service Act with respect to preparation for an influenza pandemic, including an avian influenza pandemic, and for other purposes. Lobbied for the interests of the vaccine industry. S.1422,H.R.881: A bill to amend the Federal Food, Drug, and Cosmetic Act to reduce human exposure to mercury through vaccines. Lobbied for the interests of the vaccine industry. H.R.650: To establish reasonable legal reforms that will facilitate the manufacture of vital, life-saving vaccines, and for other purposes. Lobbied for the interests of the vaccine industry. H.R.1297: To amend the Public Health Service Act with respect to the National Vaccine Injury Compensation Program. Lobbied for the interests of the vaccine industry. S.930: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. Lobbied to prevent the unreasonable restricition of legitimate medical research or clinical trials. S.470: A bill to amend the Public Health Service Act to expand the clinical trials drug data bank. Lobbied to provide the best information to the patient. H.R.2090: To amend the Federal Food, Drug, and Cosmetic Act to provide for the deposit in the general fund of the Treasury of fees that are collected from manufacturers of drugs and devices under chapter VII of such Act, to terminate the authority of the Food and Drug administration to negotiate with the manufacturers on particular uses of the fees, to establish a Center for Postmarket Drug Safety and Effectiveness, to establish additional authorities to ensure the safe and effective use of drugs, and for other purposes. Lobbied for provisions that promoted the development safe and effective drugs. H.R.2124,H.R.2308: To amend the Public Health Service Act to provide for clinical research support grants, clinical research infrastructure grants, and a demonstration program on partnerships in clinical research, and for other purposes. Lobbied for reasonable provisions that support research and clinical trials. H.R.2650: To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to protect consumers in managed care plans and other health coverage. Lobbied for the interests of the industry. H.R.2792: To permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests, and for other purposes. Lobbied for the interests of the industry. H.R.3196,H.R.2259,S.1012: To amend the Public Health Service Act to expand the scope of information required for the data bank on clinical trials of drugs, and for other purposes. Lobbied for reasonable provisions that support research and clinical trials. S.1128: A bill to amend title XIX of the Social Security Act to provide for increased rebates under the medicaid program for prescription drugs that are directly advertised to consumers, to require other Federal programs purchasing or reimbursing for such drugs to establish payment and reimbursement mechanisms that reduce the costs of those drugs, and for other purposes. Lobbied to ensure that any enacted restrictions would not impede access of the consumer to accurate information about pharmaceutical products. H.R.840,S.399: A bill to amend the Federal Food, Drug and Cosmetic Act with respect to the sale of prescription drugs through the internet, and for other purposes. Lobbied to ensure that the internet would not be used to import counterfeit and defective medical products. H.R.1808,S.334: To amend the Federal Food, Drug, and Cosmetic Act to create a uniform certification standard for Internet pharmacies and to prohibit Internet pharmacies from engaging in certain advertising activities, to prohibit the use of certain bank instruments for purchases associated with illegal Internet pharmacies, and for other purposes. Lobbied to ensure that the internet would not be used to import counterfeit and defective medical products. H.R.4395: To amend titles XVIII and XIX of the Social Security Act to provide for an improved voluntary Medicare prescription drug benefit, to provide greater access to affordable pharmaceuticals, and for other purposes. Lobbied for an exemption for biologics in the Drug Importation section. S.470: A bill to amend the Public Health Service Act to expand the clinical trials drug data bank. Lobbied to prevent the unreasonable restriction of legitimate medical research or clinical trials. S.930: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. Lobbied to prevent the unreasonable restricition of legitimate medical research or clinical trials. S.1873: A bill to prepare and strengthen the biodefenses of the United States against deliberate, accidental, and natural outbreaks of illness, and for other purposes. Lobbied for a vaccine liability and compensation program for Pandemic Vaccines. H.R.2345: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. Lobbied in support of enhanced FDA authorities over counterfeit products. H.R.3052,S.1527: Vaccine Access and Supply Act, lobbied for provisions to strengthen the domestic vaccine industry. H.R.3970: Bioterror and Pandemic Preparedness Protection Act, lobbied in support of provisions to assure domestic pandemic preparedness. S.1821: Pandemic Preparedness and Response Act, lobbied in support of provisions to assure domestic pandemic preparedness. S.1828: Influenza Vaccine Security Act of 2005, lobbied in support of provisions to assure as strong domestic vaccine industry. S.1912: Global Network for Avian Influenza Surveillance Act, lobbied in support of domestic pandemic preparedness. S.375: Flu Protection Act of 2005, lobbied in support of domestic influenza provisions to stabilize production and supply. S.969: Attacking Viral Influenza Across Nations Act of 2005, lobbied in support of influenza provisions. General matters related to vaccine industry stability, pandemic preparedness, avian influenza.

Client expense: Not reported · Firm income: $100,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

S 471 Stem Cell Research Enhancement Act of 2005 Provision for embryonic stem cell research

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 810 / S. 471 -- Stem Cell Research Enhancement Act of 2005: All titles and sections S. 1317 -- Bone Marrow and Cord Blood Therapy and Research Act of 2005: All titles and sections HR 2520 -- Stem Cell Therapeutic and Research Act of 2005: All titles and sections

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

HR 810 Stem Cell Research Enchancement Act S471 Stem Cell Research Enhancement Act of 2005

Client expense: $0 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, Small Business Administration (SBA)

HR 810/S. 471 “The Stem Cell Research Enhancement Act of 2005” communicated with and met in person with House and Senate staff regarding the scientific and ethical implications of both embryonic and adult stem cell research; requested that members of the Maryland delegation co-sponsor the legislation; participated in advocacy activities in conjunction with the Coalition for the Advancement of Medical Research (CAMR), the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC) towards the passage of the House bill and a strategy for passage in the Senate; Also monitored other stem cell related legislation , including that addressing: human cloning (S. 658/HR 1357) and regulation of so-called chimeras. Also monitored: S. 470 ‘Fair Access to Clinical Trials (FACT) Act of 2005) Responded to inquiries from the Maryland House delegation re. the participation of foster children in federally sponsored HIV/AIDS research protocols. Monitored issues involved with federal effort reporting requirements in conjunction with the Association of American Univiersities (AAU), the Amercian Association of Medical Colleges (AAMC), and the Council on Government Relations (COGR). In conjuction with efforts undertaken by the Association of American Medical Colleges (AAMC), prepared and submitted unsolicited comments related to new conflict of interest rules proposed by the Department of Health and Human Services with respect to employees of the National Institutes of Health

Client expense: $420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Natl Aeronautics & Space Administration (NASA), SENATE, State, Dept of (DOS)